GlassScriptPhysician profile
Edward Matthew Zimm
NPI 1609801604
$3,634.89
in general payments reported to CMS, 2019-2025
25 companies · $1,000 in 2025
The $1,000 reported for 2025 was more than what 77% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $467 · 2020: $74.40 · 2021: $179 · 2022: $660 · 2023: $676 · 2024: $578 · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,254.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,217.64 | 2019-2025 | Clareon, Rocklatan, Clareon Panoptix Pro |
| Abbvie INC. | $666.76 | 2022-2025 | Durysta, Vuity, Lumigan |
| Sight Sciences, INC. | $251.66 | 2023 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $222.48 | 2022-2025 | Xiidra, Miebo, Scoutpro Osmolarity System |
| Beaver-Visitec International, INC. | $201.81 | 2022-2023 | |
| Prodigy Surgical Distribution, INC. | $160.32 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $119.47 | 2019-2021 | |
| Glaukos Corporation | $106.31 | 2024-2025 | Idosetr, Idose |
| Allergan, INC. | $94.03 | 2019-2022 | |
| Carl Zeiss Meditec USA, INC. | $76.56 | 2022 | |
| Ivantis, INC | $59.76 | 2020-2021 | |
| Thea Pharma INC. | $55.87 | 2024-2025 | Iyuzeh |
| Ocular Therapeutix, INC. | $55.70 | 2025 | Dextenza |
| New World Medical,INC. | $50.95 | 2022-2025 | Clearpath, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Dompe US, INC. | $50.18 | 2021-2025 | Oxervate |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $42.26 | 2023-2024 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $36.25 | 2022-2023 | |
| Rayner Intraocular Lenses Limited | $34.42 | 2022 | |
| Rxsight INC | $27.21 | 2022 | |
| Biotissue Holdings INC. | $24.77 | 2025 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Aerie Pharmaceuticals, INC. | $16.73 | 2019 | |
| Omeros Corporation | $16.06 | 2021 | |
| Eyevance Pharmaceuticals LLC | $15.35 | 2022 | |
| Lkc Technologies, INC. | $12.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Zimm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.